Medical MCQ
MCQ Ebook
Biochemistry
Microbiology
Pathology
MCQ Subjects
Anaesthesia
Anatomy
Biochemistry
Dental
ENT
Forensic Medicine
Gynaecology & Obstetrics
Medicine
Microbiology
Ophthalmology
Orthopaedics
Pathology
Pediatrics
Pharmacology
Physiology
Psychiatry
Radiology
Skin
Social & Preventive Medicine
Surgery
Others
MCQ Exam
Anaesthesia
Anatomy
Biochemistry
Dental
ENT
Forensic Medicine
Gynaecology & Obstetrics
Medicine
Microbiology
Ophthalmology
Orthopaedics
Pathology
Pediatrics
Pharmacology
Physiology
Psychiatry
Radiology
Skin
Social & Preventive Medicine
Surgery
Others
All MCQs
Term Of Use
Privacy Policy
Contact Us
About Us
Home
Ebooks
Questions
Search
Pharmacology
All of the following statements about the use of spironolactone in CHF are true except:
It should be administered in low doses to prevent hyperkalemia
It affords prognostic benefit in severe heart failure over and above that afforded by ACE inhibitors
It helps to overcome the refractoriness to thiazides
It affords rapid symptomatic relief in CHF patients
Questions
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100